M B Youdim, J P Finberg. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAlkynes/therapeutic useAnimalsBrain/drug effectsDrug Therapy, CombinationHumansIndans/therapeutic useIsoenzymes/metabolismLevodopa/therapeutic useMonoamine Oxidase/metabolismMonoamine Oxidase Inhibitors/therapeutic usePargyline/analogs & derivativesParkinson Disease/drug therapyParkinson Disease/enzymologyParkinson Disease, Secondary/drug therapyParkinson Disease, Secondary/enzymologyPyridines/toxicityReceptors, Dopamine/drug effectsSelegiline/therapeutic useStructure-Activity RelationshipTyramine/antagonists & inhibitors
Substances： See more » AlkynesIndansIsoenzymesMonoamine Oxidase InhibitorsPyridinesReceptors, DopaminerasagilineSelegilineLevodopaN-methyl-N-propargyl-(1-indanyl)-ammonium hydrochloridePargyline1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineMonoamine OxidaseTyramine
Year: 1987 PMID： 3103383
Source DB: PubMed Journal: Adv Neurol ISSN： 0091-3952